Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells
2012
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Immunotherapy of cancer in 2012
2012
Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
2009
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Current oral treatments for erectile dysfunction
2002
Emerging Pharmacologic Approaches for the Treatment of Lower Urinary Tract Disorders
2004
Parkinson disease
2017 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
Cellular Vaccine Approaches
2010
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
2011
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Antidepressants and sexual dysfunction
2006
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
2012
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
2012 StandoutNobel
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
2012
Delivery technologies for cancer immunotherapy
2019 Standout
URODYNAMICS AND MULTIPLE SCLEROSIS
1996
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Nanoparticles for dendritic cell-based immunotherapy
2018
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Central nervous system-acting agents and the treatment of erectile and sexual dysfunction
2007
Attenuated T Cell Responses to a High-Potency Ligand In Vivo
2010 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Biomaterials for vaccine-based cancer immunotherapy
2018
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
2011 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Inducible expression of a prostate cancer‐testis antigen, SSX‐2, following treatment with a DNA methylation inhibitor
2007
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Non-motor features of Parkinson disease
2017 Standout
The ChEMBL database in 2017
2016 Standout
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Regulatory T cells in tumor immunity
2010 StandoutNobel
Therapeutic Cancer Vaccines
2013
The colony-stimulating factors and cancer
2010
Neutrophils in cancer: neutral no more
2016 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Allogeneic tumor cell vaccines
2013
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
An analysis of the attrition of drug candidates from four major pharmaceutical companies
2015 Standout
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
2003 Standout
Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients
2011
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
2002
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Pharmacology of Penile Erection
2001
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Recent Progress in GM-CSF-Based Cancer Immunotherapy
2017
Cancer Genome Landscapes
2013 StandoutScience
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Biomedical Importance of Indoles
2013 Standout
Whole Tumor Antigen Vaccines: Where Are We?
2015
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Works of Eugene Dula being referenced
Role of urologist in diagnosis ofmultiple sclerosis
1991
Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction
2000
Double–Blind, Crossover Comparison of 3 mg Apomorphine SL with Placebo and with 4 mg Apomorphine SL in Male Erectile Dysfunction
2001
Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer
2007